Abstract
Cyclopropanols have found an increasing number of uses as synthetic intermediates and as functional groups in the design of enzyme inhibitors. This mini-review will discuss some of the most recent and successful methodologies for the synthesis of these entities, focusing mainly on the stereoselective transformations. The new procedure developed in our group for the preparation of cyclopropanols in chiral form is also reviewed.
Keywords: Cyclopropanols, stereoselective synthesis
Mini-Reviews in Organic Chemistry
Title: Stereoselective Synthesis of Cyclopropanols
Volume: 3 Issue: 4
Author(s): P. Garcia, D. Diez, A. B. Anton, N. M. Garrido, I. S. Marcos, P. Basabe and J. G. Urones
Affiliation:
Keywords: Cyclopropanols, stereoselective synthesis
Abstract: Cyclopropanols have found an increasing number of uses as synthetic intermediates and as functional groups in the design of enzyme inhibitors. This mini-review will discuss some of the most recent and successful methodologies for the synthesis of these entities, focusing mainly on the stereoselective transformations. The new procedure developed in our group for the preparation of cyclopropanols in chiral form is also reviewed.
Export Options
About this article
Cite this article as:
Garcia P., Diez D., Anton B. A., Garrido M. N., Marcos S. I., Basabe P. and Urones G. J., Stereoselective Synthesis of Cyclopropanols, Mini-Reviews in Organic Chemistry 2006; 3 (4) . https://dx.doi.org/10.2174/157019306778742878
DOI https://dx.doi.org/10.2174/157019306778742878 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [Hot Topic: Sepsis: Evolving Concepts and Therapeutic Strategies (Executive Editors: T.J. Standiford and M. Moss) ]
Current Pharmaceutical Design Nanofibers: New Insights for Drug Delivery and Tissue Engineering
Current Topics in Medicinal Chemistry Atrial Fibrillation with a Focus on Oral Antiarrhythmic Therapy
Current Drug Therapy Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders
Current Topics in Medicinal Chemistry Mucosal Immunisation: Adjuvants and Delivery Systems
Current Drug Delivery The Role of B Cells in Multiple Sclerosis: Implications for B-Cell-Targeted Therapy
Current Medicinal Chemistry Lipid Lowering Agents and the Endothelium: An Update after 4 Years
Current Vascular Pharmacology Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder
Current Neuropharmacology Critical Roles for Bradykinin and Prostanoids in Acute Inflammatory Reactions: A Search Using Experimental Animal Models
Current Drug Targets - Inflammation & Allergy New Conjugates of Tuftsin and Muramyl Dipeptide as Stimulators of Human Monocyte-Derived Dendritic Cells
Protein & Peptide Letters Selenium and Neurological Diseases: Focus on Peripheral Pain and TRP Channels
Current Neuropharmacology Potential Targets for Anti-Inflammatory and Anti-Allergic Activities of Marine Algae: An Overview
Inflammation & Allergy - Drug Targets (Discontinued) Molecules to Selectively Target Receptors for Treatment of Pain and Neurogenic Inflammation
Recent Patents on Inflammation & Allergy Drug Discovery Pharmacological Approaches to Targeting Muscarinic Acetylcholine Receptors
Recent Patents on CNS Drug Discovery (Discontinued) Insights into Targeting NEMO for Pharmacological Regulation
Current Drug Targets siRNA Therapy, Challenges and Underlying Perspectives of Dendrimer as Delivery Vector
Current Pharmaceutical Design Cardiac Effects of HDL and Its Components on Diabetic Cardiomyopathy
Endocrine, Metabolic & Immune Disorders - Drug Targets ADAM8/MS2/CD156, an Emerging Drug Target in the Treatment of Inflammatory and Invasive Pathologies
Current Pharmaceutical Design The Role of Serum Calprotectin as a New Marker in Abdominal Aortic Aneurysms – A Preliminary Report
Current Pharmaceutical Biotechnology Drug Resistance Mutations from Whole Blood Proviral DNA Among Patients on Antiretroviral Drugs in Zimbabwe
Current HIV Research